(Q43247698)

English

Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT).

scientific article published on 5 November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT). (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

systolic heart failure

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

6

object named as

Luigi Tavazzi

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

2

object named as

Michel Komajda

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1

object named as

Karl Swedberg

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

author name string

Michael Böhm

3

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Jeffrey S Borer

4

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

Ian Ford

5

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

publication date

5 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

75-81

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Resting heart rate in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Predictors of mortality and morbidity in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Funny channels in the control of cardiac rhythm and mode of action of selective blockers.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

I f inhibition with ivabradine : electrophysiological effects and safety

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

EuroQol: the current state of play

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

The myocardium in congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Heart rate reduction--a mechanism of benefit?

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Heart failure in a district general hospital: are target doses of beta-blockers realistic?

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Adequacy of diagnosis and treatment of chronic heart failure in primary health care in Sweden

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP154

21 January 2018

Identifiers

10.1093/EURJHF/HFP154

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43247698&oldid=1602267099"